| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 230.927 | 85 |
| GSM780708 | Untreated after 4 days (C2_1) | 184.594 | 83 |
| GSM780709 | Untreated after 4 days (C3_1) | 176.631 | 82 |
| GSM780719 | Untreated after 4 days (C1_2) | 232.547 | 85 |
| GSM780720 | Untreated after 4 days (C2_2) | 214.284 | 84 |
| GSM780721 | Untreated after 4 days (C3_2) | 176.168 | 82 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 199.605 | 84 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 200.409 | 84 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 257.43 | 86 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 190.532 | 83 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 197.507 | 83 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 249.545 | 86 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 191.206 | 83 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 184.307 | 83 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 195.032 | 83 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 178.622 | 82 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 209.361 | 84 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 228.757 | 85 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 196.961 | 83 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 227.725 | 85 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 197.08 | 83 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 203.481 | 84 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 207.614 | 84 |